Company / Working Capital per Share
OCULAR THERAPEUTIX, INC Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.64
FY2025
5-year range
$1.28 / $4.64
FY2021-FY2025
Trend
+33.4%
vs FY2024
Sector context
#113 of 210
Health Care
What the data says
At $4.64, OCULAR THERAPEUTIX, INC's working capital per share ranks #113 of 210 in the Health Care sector. Working Capital per Share has increased for 3 consecutive years, from $1.28 in FY2022 to $4.64 in FY2025.
Based on SEC 10-K filings.
4.64 in FY2025 with a 5-year CAGR of +1.2%.
Improved from $2.56 to $4.64 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +53.6%
- 5-Year CAGR
- +1.2%
- 10-Year CAGR
- -
Sector benchmark
#113 of 210 in Health CareTop 54% of 210This company $4.64 Sector average $118.60
▼
-96.1% below sector average
Key checks
Key Insights
- OCULAR THERAPEUTIX, INC's working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 33.4% year-over-year.
- Ranks #113 out of 210 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.64 | +33.4% |
| FY2024 | $3.48 | +36.0% |
| FY2023 | $2.56 | +99.7% |
| FY2022 | $1.28 | -41.0% |
| FY2021 | $2.17 | -50.2% |
| FY2020 | $4.36 | +276.1% |
| FY2019 | $1.16 | -26.9% |
| FY2018 | $1.59 | +32.7% |
| FY2017 | $1.20 | -52.0% |
| FY2016 | $2.49 | -47.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026